nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial
|
Falchook, Gerald S |
|
2012 |
13 |
8 |
p. 782-789 8 p. |
artikel |
2 |
Adjuvant nodal irradiation in melanoma
|
Khattak, Muhammad |
|
2012 |
13 |
8 |
p. e326-e327 nvt p. |
artikel |
3 |
Adjuvant nodal irradiation in melanoma – Authors' reply
|
Burmeister, Bryan |
|
2012 |
13 |
8 |
p. e327- 1 p. |
artikel |
4 |
Angelight Films: lights, camera, cancer!
|
Astudillo, Olaya |
|
2012 |
13 |
8 |
p. 770-771 2 p. |
artikel |
5 |
Antiangiogenic treatment in metastatic urothelial cancer
|
Galsky, Matthew D |
|
2012 |
13 |
8 |
p. 748-749 2 p. |
artikel |
6 |
Australia to be first country to vaccinate boys against HPV
|
Kirby, Tony |
|
2012 |
13 |
8 |
p. e333- 1 p. |
artikel |
7 |
Biomarkers for early diagnosis of hepatocellular carcinoma
|
Forner, Alejandro |
|
2012 |
13 |
8 |
p. 750-751 2 p. |
artikel |
8 |
Biomarkers in personalised treatment of renal-cell carcinoma
|
Shariat, Shahrokh F |
|
2012 |
13 |
8 |
p. 751-752 2 p. |
artikel |
9 |
Breast cancer in Mexico: a growing challenge to health and the health system
|
Chávarri-Guerra, Yanin |
|
2012 |
13 |
8 |
p. e335-e343 nvt p. |
artikel |
10 |
Cancer care in South Africa
|
Szpak, W |
|
2012 |
13 |
8 |
p. e324-e325 nvt p. |
artikel |
11 |
Cancer care in South Africa
|
Pretorius, Lauren |
|
2012 |
13 |
8 |
p. e325- 1 p. |
artikel |
12 |
Cancer care in South Africa
|
Abratt, Raymond P |
|
2012 |
13 |
8 |
p. e324- 1 p. |
artikel |
13 |
Cancer detection in primary care
|
Rubin, Greg |
|
2012 |
13 |
8 |
p. e325-e326 nvt p. |
artikel |
14 |
Cancer transition and priorities for cancer control
|
Maule, Milena |
|
2012 |
13 |
8 |
p. 745-746 2 p. |
artikel |
15 |
Chemokine receptor blockade in graft-versus-host disease
|
Brower, Vicki |
|
2012 |
13 |
8 |
p. e333- 1 p. |
artikel |
16 |
CNS PNET molecular subgroups with distinct clinical features
|
von Bueren, André O |
|
2012 |
13 |
8 |
p. 753-754 2 p. |
artikel |
17 |
Cytoreductive surgery plus hyperthermic perioperative chemotherapy to treat peritoneal metastases from colorectal cancer: standard of care or an experimental approach?
|
Sugarbaker, Paul H |
|
2012 |
13 |
8 |
p. e362-e369 nvt p. |
artikel |
18 |
Data used to justify Indian HPV vaccination trial questioned
|
Bhaumik, Soumyadeep |
|
2012 |
13 |
8 |
p. e330- 1 p. |
artikel |
19 |
Dear video diary…
|
Penny, Helen |
|
2012 |
13 |
8 |
p. 772- 1 p. |
artikel |
20 |
Death of a Superhero
|
Yaqub, Farhat |
|
2012 |
13 |
8 |
p. 769- 1 p. |
artikel |
21 |
Elderly people with glioblastoma
|
Chamberlain, Marc C |
|
2012 |
13 |
8 |
p. e328-e329 nvt p. |
artikel |
22 |
Elderly people with glioblastoma
|
Fiorentino, Alba |
|
2012 |
13 |
8 |
p. e327-e328 nvt p. |
artikel |
23 |
Elderly people with glioblastoma – Authors' reply
|
Wick, Wolfgang |
|
2012 |
13 |
8 |
p. e329- 1 p. |
artikel |
24 |
European Medicines Agency assesses safety reporting at Roche
|
Marshall, Hilary |
|
2012 |
13 |
8 |
p. e331- 1 p. |
artikel |
25 |
Global cancer transitions according to the Human Development Index (2008–2030): a population-based study
|
Bray, Freddie |
|
2012 |
13 |
8 |
p. 790-801 12 p. |
artikel |
26 |
Go With the Flow
|
O'Donoghue, Odhran |
|
2012 |
13 |
8 |
p. 771-772 2 p. |
artikel |
27 |
Healthy choice should be the easy choice
|
The Lancet Oncology, |
|
2012 |
13 |
8 |
p. 743- 1 p. |
artikel |
28 |
Lapatinib or trastuzumab in combination with an aromatase inhibitor for first-line treatment of metastatic hormone-receptor-positive breast cancer that overexpresses HER2
|
Doss, Sally |
|
2012 |
13 |
8 |
p. 766-767 2 p. |
artikel |
29 |
Markers for individualised therapy in endometrial carcinoma
|
Salvesen, Helga B |
|
2012 |
13 |
8 |
p. e353-e361 nvt p. |
artikel |
30 |
Markers of survival and metastatic potential in childhood CNS primitive neuro-ectodermal brain tumours: an integrative genomic analysis
|
Picard, Daniel |
|
2012 |
13 |
8 |
p. 838-848 11 p. |
artikel |
31 |
Natural gamma radiation and childhood leukaemia
|
Gilbert, Judith A |
|
2012 |
13 |
8 |
p. e332- 1 p. |
artikel |
32 |
NICE guidance on abiraterone for castration-resistant metastatic prostate cancer previously treated with a docetaxel-containing regimen
|
Dyer, Matthew |
|
2012 |
13 |
8 |
p. 762-763 2 p. |
artikel |
33 |
NICE guidance on erlotinib for first-line treatment of EGFR-TK mutation-positive advanced or metastatic non-small-cell lung cancer
|
Dillon, Bernice |
|
2012 |
13 |
8 |
p. 764-765 2 p. |
artikel |
34 |
One in five need reoperation after breast-conserving surgery
|
Bennet, Neil |
|
2012 |
13 |
8 |
p. e334- 1 p. |
artikel |
35 |
Parent-controlled analgesia for paediatric pain management
|
Chen-See, Sherene |
|
2012 |
13 |
8 |
p. e332- 1 p. |
artikel |
36 |
Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis
|
Senthi, Sashendra |
|
2012 |
13 |
8 |
p. 802-809 8 p. |
artikel |
37 |
Pazopanib in advanced and platinum-resistant urothelial cancer: an open-label, single group, phase 2 trial
|
Necchi, Andrea |
|
2012 |
13 |
8 |
p. 810-816 7 p. |
artikel |
38 |
Potential therapeutic target for triple-negative breast cancer
|
Gilbert, Judith A |
|
2012 |
13 |
8 |
p. e330- 1 p. |
artikel |
39 |
Preimplantation genetic diagnosis for mutated BRCA genes
|
Wilkinson, Emma |
|
2012 |
13 |
8 |
p. e331- 1 p. |
artikel |
40 |
Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trials
|
Tran, Hai T |
|
2012 |
13 |
8 |
p. 827-837 11 p. |
artikel |
41 |
Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial
|
Infante, Jeffrey R |
|
2012 |
13 |
8 |
p. 773-781 9 p. |
artikel |
42 |
Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study
|
Shen, Qiujin |
|
2012 |
13 |
8 |
p. 817-826 10 p. |
artikel |
43 |
Stereotactic ablative radiotherapy for inoperable stage I NSCLC
|
Andratschke, Nicolaus |
|
2012 |
13 |
8 |
p. 746-748 3 p. |
artikel |
44 |
The Cancer Drug Fund 1 year on—success or failure?
|
Stephens, Peter |
|
2012 |
13 |
8 |
p. 754-757 4 p. |
artikel |
45 |
The coming of age of MEK
|
McArthur, Grant A |
|
2012 |
13 |
8 |
p. 744-745 2 p. |
artikel |
46 |
The state of chemotherapy in France
|
Lochouarn, Martine |
|
2012 |
13 |
8 |
p. 761- 1 p. |
artikel |
47 |
14th World Congress on Gastrointestinal Cancer
|
Brierley, Rob |
|
2012 |
13 |
8 |
p. 768- 1 p. |
artikel |
48 |
Treatment decisions for elderly patients with haematological malignancies: a dilemma
|
Peyrade, Frédéric |
|
2012 |
13 |
8 |
p. e344-e352 nvt p. |
artikel |
49 |
US Medicare to cut radiotherapy times and payments
|
Furlow, Bryant |
|
2012 |
13 |
8 |
p. e334- 1 p. |
artikel |
50 |
US Supreme Court paves way for health reform
|
Furlow, Bryant |
|
2012 |
13 |
8 |
p. 759-760 2 p. |
artikel |
51 |
Voices from the front: August
|
Mastrianni, David M |
|
2012 |
13 |
8 |
p. 772- 1 p. |
artikel |
52 |
Will the medical student in the team please stand up?
|
dos Anjos, Gabriel |
|
2012 |
13 |
8 |
p. 757-758 2 p. |
artikel |